[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-331308-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-331308-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cervical-cancer-screening-utilization-and-associated-factors-among-women-living-with-hiv-in-ethiopia-2024-systematic-review-and-meta-analysis","Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024 - systematic review and meta-analysis","","Cervical cancer remains a major global health challenge, with most cases and deaths concentrated in low-resource settings such as Ethiopia. Women living with HIV face a substantially elevated risk—about six times higher than women without HIV—while both screening service availability and use are low, especially among women living with HIV. This systematic review and meta-analysis synthesized evidence on screening utilization prevalence and its associated factors in Ethiopia, drawing on studies published from 2015 to 2023.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cervical-cancer-screening-utilization-and-associated-factors-among-women-living-with-hiv-in-ethiopia-2024-systematic-review-and-meta-analysis/331308/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cervical-cancer-screening-utilization-and-associated-factors-among-women-living-with-hiv-in-ethiopia-2024-systematic-review-and-meta-analysis/331308.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this study?","Question",{"text":63,"@type":64},"The study synthesizes evidence on the prevalence of cervical cancer screening utilization and identifies factors associated with screening among women living with HIV in Ethiopia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the data analyzed?",{"text":68,"@type":64},"The authors conducted a systematic review and meta-analysis, extracting data from included studies, organizing extracted data in Excel, and analyzing using STATA 17 with a random-effect model.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the overall prevalence of cervical cancer screening utilization?",{"text":72,"@type":64},"The pooled prevalence was 24% (with a 17–32% range) among women living with HIV in Ethiopia.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},331308,1790158790,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Yirsaw et al. BMC Women's Health (2024) 24:521 BMC Women's Health  \n[https://doi.org/10.1186/s12905-024-03362-y](https://doi.org/10.1186/s12905-024-03362-y)  \nSYSTEMATIC REVIEW Open Access  \nCervical cancer screening utilization   \nand associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis  \nAmlaku NigusieYirsaw 1*, Adane Nigusie 1,6, Fantahun Andualem3, Eyob Getachew 1, Demis Getachew4, Abiyu AbadiTareke5, Muhabaw Shumye Mihret2 and Gebeyehu Lakew 1  \nAbstract  \nBackground Cervical cancer is a significant global health challenge, with the majority of cases and deaths occurring in low-resource regions like sub-Saharan Africa including Ethiopia. Women living with HIV (WLHIV) in this area face a six-fold higher risk of cervical cancer compared to women living without HIV Both the availability of screening services and their utilization remain low, particularly among WLHIV, hindering efforts to reduce the cervical cancer burden in this vulnerable population.  \nObjective This study aimed to synthesize the current research on the prevalence of cervical cancer screening utilization and the associated factors among women living with HIV in Ethiopia.  \nMethod We conducted a comprehensive systematic review and meta-analysis, searching databases such as Google Scholar, PubMed, and the Cochrane Library for relevant studies published from 2015 up to 2023 and the search period for these relevant articles was from April 1 up to April 30, 2024. Data from included studies was extracted, organized in Excel, and then analyzed using STATA 17. The overall effect across all studies was calculated using a random-effect model. Potential publication bias and heterogeneity in the results between studies were assessed using Egger’s test, forest plot, and I² statistic, respectively.  \nResult According to the systematic review and meta-analysis, the overall prevalence of cervical cancer screening utilization among women living with HIV in Ethiopia was 24%(17 − 32%) . Several factors were independently associated with cervical cancer screening utilization, including age (40–49) years (OR = 3 . 95, 95% CI: 3 .307–4. 595), age (18–29) years (OR = 5 . 021, 95% CI: 1.563–9.479), education level greater than college (OR = 3 . 293, 95% CI: 1.835–4. 751), having good knowledge (OR = 3 .421, 95% CI: 2 .928–3. 915), early initiation of sexual intercourse (OR = 3 .421, 95%  \nCI: 2 .928–3. 915), awareness of cervical cancer (OR = 3 . 551, 95% CI: 2 .945–4. 157), having information about cancer (OR = 3 . 671, 95% CI: 2 .606–4. 736), CD4 count less than 500 cell/mm3 (OR = 4 . 001, 95% CI: 1.463–6. 539), government employee (OR = 5 . 921, 95% CI: 1.767–10. 076), and perceived susceptibility (OR = 2 . 950, 95% CI: 2 .405–3.496) .  \n*Correspondence:  \nAmlaku NigusieYirsaw [amlakunigusie1616@gmail.com](amlakunigusie1616@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.","cbCair7nMSuhrywS","https://ap.wps.com/l/cbCair7nMSuhrywS","pdf",3320978,14,"English","# Abstract\n## Background\n## Objective\n## Method\n## Result\n## Conclusion\n## Keywords\n# Background","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study synthesizes evidence on the prevalence of cervical cancer screening utilization and identifies factors associated with screening among women living with HIV in Ethiopia.\"},{\"question\":\"How were the data analyzed?\",\"answer\":\"The authors conducted a systematic review and meta-analysis, extracting data from included studies, organizing extracted data in Excel, and analyzing using STATA 17 with a random-effect model.\"},{\"question\":\"What was the overall prevalence of cervical cancer screening utilization?\",\"answer\":\"The pooled prevalence was 24% (with a 17–32% range) among women living with HIV in Ethiopia.\"}]","Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024 - systematic review and meta-analysis | PDF",1789992603,35]